Rich respiratory biomarker and diagnostic information in near-real-time from a single breath recording through N-Tidal
Unprecedented accuracy for detecting respiratory physiology through novel, validated digital biomarkers on a regulated platform
Relaxed breathing through the N-Tidal Handset (CE), containing our CO2 sensing technology
Automatic 4G data transfer.
Real-time digital biomarker generation on cloud
TidalSense AI engine
N-Tidal Diagnose
Class 2a EU MDR CE-marked diagnostic AI software
N-Tidal Capture
Class 1 CE-marked remote monitoring software
Underdiagnosis, misdiagnosis and late diagnosis of COPD with spirometry results in billions of wasted resource, larger sample sizes and longer time to reach sufficient power. Use N-Tidal Diagnose (CE) in your trials to screen patients in under 5 minutes. Unlike spirometry, N-Tidal Diagnose is specific, as it is able to detect the underlying airway remodelling that occurs in obstructive airway diseases.
N-Tidal Capture (CE) provides longitudinal monitoring of any patients with cardiorespiratory conditions using our obstructive airway biomarkers. Our trials dashboard enables adherence tracking and real-time data quality indicators.
Gain back-end access to all of our N-Tidal biomarkers (both regulated and R&D biomarkers) which power our clinical solutions along with our AI pipelines for clinical trials research. Integrating N-Tidal into trials will unlock new datastreams, including biomarkers relating to:
We're on a mission to transform respiratory pathways globally to drive efficiency, diagnose the undiagnosed, and push towards data-driven therapeutic management, ensuring patients are on the right treatments at an early stage to improve outcomes.
UK programme designed to rapidly diagnose patients on waiting lists through rapid testing using N-Tidal Diagnose.
UK programme designed to embed N-Tidal Diagnose within N-Tidal breathlessness pathways to screen for patients who are eligible for biologics or triple therapy.
Support our worldwide evidence generation programme designed to grow our body of real-world evidence and develop new indications to launch on the N-Tidal platforms.